Shares vaulted as IBM and the U.S. Department of Commerce unveiled a $2 billion plan to build the country's first dedicated quantum chip factory — a deal that has added roughly $40 to the stock in four trading days. The question facing investors: how much future should you pay for today?
Washington Is Betting Half the Tab, and That Changes the Math
The new subsidiary, called Anderon, will be America's first pure-play quantum foundry, funded by $1 billion in CHIPS Act incentives and a matching $1 billion cash commitment from IBM.
It will be based in Albany, New York. For shareholders, the government backstop effectively halves IBM's upfront risk on a moonshot technology. The Commerce Department signed letters of intent across nine quantum companies totaling $2.013 billion, making this the largest single U.S. government quantum intervention to date.
However, a letter of intent is not a binding award; funds are released against milestones, and equity terms remain undisclosed.
IBM Wants to Be the TSMC of Quantum — Selling Picks and Shovels
Anderon plans to offer wafer fabrication for multiple quantum technology vendors worldwide — essentially positioning IBM as the contract manufacturer for an entire emerging industry. This gives IBM another avenue to turn its quantum spending into revenue.
IBM has already deployed over 90 quantum systems globally — more than all other industry players combined — but none yet generate meaningful standalone revenue.
The Stock Was Beaten Down, So This News Landed on Dry Tinder
Shares were down 21% year-to-date before this week's rally, partly after a 13% single-day drop in February when investors feared AI tools could threaten IBM's mainframe and consulting businesses. The quantum news, paired with new AI product launches, drove a combined surge of over 11% in a single session.
Revenue Is Years Away — The 2029 Target Is the Real Test
IBM remains on track to deliver a large-scale, fault-tolerant quantum computer by 2029 — the milestone where quantum shifts from experiment to commercial product. Meanwhile, Q1 2026 revenue hit $15.92 billion (up 9%), and management guided for more than 5% full-year growth with a $1 billion increase in free cash flow.
Analysts project roughly 5% annual revenue and earnings growth through 2028 , meaning the quantum upside is not in current estimates. That's the opportunity — and the risk.